PRPH (ProPhase Labs) Total Assets: $59.87 Mil (As of Dec. 2025)


What is ProPhase Labs Total Assets?

ProPhase Labs PRPH +9.77% Total Assets is $59.87 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

ProPhase Labs's Total Assets for the quarter that ended in Dec. 2025 was $59.87 Mil.

During the past 12 months, ProPhase Labs's average Total Assets Growth Rate was -4.40% per year. During the past 3 years, the average Total Assets Growth Rate was -5.20% per year. During the past 5 years, the average Total Assets Growth Rate was 14.00% per year. During the past 10 years, the average Total Assets Growth Rate was 26.00% per year.

During the past 13 years, ProPhase Labs's highest 3-Year average Total Assets Growth Rate was 168.10%. The lowest was -20.70%. And the median was -1.00%.

Total Assets is connected with ROA %. ProPhase Labs's annualized ROA % for the quarter that ended in Dec. 2025 was -47.13%. Total Assets is also linked to Revenue through Asset Turnover. ProPhase Labs's Asset Turnover for the quarter that ended in Dec. 2025 was 0.01.

ProPhase Labs  (OTCPK:PRPH) Total Assets Explanation

Total Assets is connected with ROA %.

ProPhase Labs's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-29.592/( (65.702+59.871)/ 2 )
=-29.592/62.7865
=-47.13 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

ProPhase Labs's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.784/( (65.702+59.871)/ 2 )
=0.784/62.7865
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

ProPhase Labs Total Assets Related Terms

ProPhase Labs Total Assets Historical Data

* Premium members only.

The historical data trend for ProPhase Labs's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProPhase Labs Total Assets Chart

ProPhase Labs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.30 87.65 91.93 63.20 59.87

ProPhase Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.20 50.11 42.04 65.70 59.87

ProPhase Labs Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

ProPhase Labs's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=3.508+56.363
=59.87

ProPhase Labs's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=3.508+56.363
=59.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $59.87 Mil mean?
ProPhase Labs (PRPH) has a Total Assets of $59.87 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on ProPhase Labs and its competitors.
Is ProPhase Labs' Total Assets too high?
ProPhase Labs' current Total Assets is $59.87 Mil.
How does ProPhase Labs' Total Assets compare to NSTM and IDTA?
ProPhase Labs' Total Assets of $59.87 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Diagnostics & Research company?
A good Total Assets depends on the Medical Diagnostics & Research industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on ProPhase Labs and its competitors. ProPhase Labs's current Total Assets is $59.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProPhase Labs stock overvalued right now?
Based on GuruFocus' analysis, ProPhase Labs (PRPH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.65, compared to a current price of $0.10 — trading 84.6% below its estimated fair value. The current Total Assets is $59.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For ProPhase Labs (PRPH), the current Total Assets is $59.87 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProPhase Labs Business Description

Address 626 RXR Plaza, 6th Floor, Uniondale, NY, USA, 11556
ProPhase Labs Inc oriented and diversified next generation biotech, genomics and consumer products company that develops and commercializes novel drugs, dietary supplements, and compounds, and human genomic testing. It offer whole genome sequencing and related services. It maintain two operating segments: diagnostic services (which includes its COVID-19 and other diagnostic testing services) and consumer products. It generates majority of revenue from consumer products segment which engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services.